Alnylam’s Anant Murthy on making it as a US biotech in EuropeAlnylam’s European head of market access and GM of mid-size markets, Anant Murthy, shares his perspective on how Share XAlnylam’s Anant Murthy on making it as a US biotech in Europehttps://pharmaphorum.com/r-d/views-analysis-r-d/alnylam-anant-murthy-on-making-it-as-a-us-biotech-in-europe/
When healthcare met digital health: the next chapter of pharmaphorumBack in 2009, when I was living in Windsor, I remember walking to the pub with my wife Share XWhen healthcare met digital health: the next chapter of pharmaphorumhttps://pharmaphorum.com/views-analysis-digital/when-healthcare-met-digital-health-the-next-chapter-of-pharmaphorum/
Janssen’s Gaëtan Leblay on leading during the COVID-19 crisisCOVID-19 is putting unimaginable pressure on healthcare systems and the companies looking for solutions to end the pandemic. Share XJanssen’s Gaëtan Leblay on leading during the COVID-19 crisishttps://pharmaphorum.com/r-d/views-analysis-r-d/janssens-gaetan-leblay-on-leading-during-the-covid-19-crisis/
Has COVID-19 forever changed the way pharma does business?There’s no doubt that the COVID-19 pandemic has thrust digital engagement into the spotlight for the pharmaceutical industry Share XHas COVID-19 forever changed the way pharma does business?https://pharmaphorum.com/views-and-analysis/has-covid-19-forever-changed-the-way-pharma-does-business/
AstraZeneca: pharma needs to lead by example on sustainabilityPaul Tunnah sat down with AstraZeneca’s vice president of sustainability strategy and engagement Jim Massey to discuss how Share XAstraZeneca: pharma needs to lead by example on sustainabilityhttps://pharmaphorum.com/views-analysis-sales-marketing/astrazeneca-pharma-needs-to-lead-by-example-on-sustainability/
Engaging with customers in a digital worldAs part of our series on customer experience in pharma, in partnership with Indegene, Ipsen’s Paul Murasko explains Share XEngaging with customers in a digital worldhttps://pharmaphorum.com/views-analysis-digital/engaging-with-customers-in-a-digital-world/
Sanofi’s Bozidar Jovicevic on how the company is approaching digital therapeuticsPaul Tunnah caught up with Sanofi’s vice president, global head of digital therapeutics at JP Morgan to talk Share XSanofi’s Bozidar Jovicevic on how the company is approaching digital therapeuticshttps://pharmaphorum.com/video/sanofis-bozidar-jovicevic-on-how-the-company-is-approaching-digital-therapeutics/
UCB’s James Musick on embracing digital therapeuticsDigital has rapidly taken over the pharma industry, but many still don’t fully understand how to harness it. Share XUCB’s James Musick on embracing digital therapeuticshttps://pharmaphorum.com/views-analysis-digital/ucbs-james-musick-on-embracing-digital-therapeutics/
Millendo’s Julia Owens on leadership in rare diseasesRare disease specialists Millendo Therapeutics are hoping their drug livoletide will become the first treatment for Prader-Willi syndrome. Share XMillendo’s Julia Owens on leadership in rare diseaseshttps://pharmaphorum.com/r-d/views-analysis-r-d/millendo-julia-owens-leadership-rare-diseases/
